Researchers at IISER Bhopal, Nebraska University identify drug that can be repurposed to treat COVID-19 Read more
Pharma MSMEs seek government intervention to tackle shortage, price increase of raw materials Read more
Low patient accrual rates cause termination of over 25 per cent rare disease trials: GlobalData Read more
Lilly’s bamlanivimab plus etesevimab cut death, hospitalisations for early COVID-19 in Phase III trial Read more